Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples

Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples

US Patent 7732159 · Granted Jun 8, 2010

Estimated economic value: $1,297,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fluid flow control apparatus2012
Assays for cancer patient monitoring based on levels of epidermal growth factor 2009
Assays for cancer patient monitoring based on levels of epidermal growth factor 2009
Detection and quantification of neu related proteins in the biological fluids of2005
Detection, quantitation and classification of ras proteins in body fluids and ti2001
Detection of neu p185 in cell lysates1997
Polymers for electroluminescent devices1996
Detection, quantitation and classification of RAS proteins in body fluids and ti1995
Detection and quantification of neu related proteins in the biological fluids of1995
Antibodies reactive with normal and oncogenic forms of the ras p21 protein1993
Monoclonal antibodies against activated ras proteins with amino acid mutations a1992
Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins1992